Author:
Rava Paul S.,DiPetrillo Thomas A.
Reference49 articles.
1. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. IJROBP. 1991;21:109–22.
2. Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. IJROBP. 2010;76(3):S10–9.
3. Kuban DA, Tucker SL, Dong L, et al. Long-term results of the MD Anderson randomized dose-escalation trial for prostate cancer. IJROBP. 2008;70:67–75.
4. Zeitman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized control trial. JAMA. 2005;294:1233–40.
5. Sathya JR, Davis IR, Julian JA, et al. Randomized trial comparing iridium implant plus external beam radiation therapy with external beam radiation therapy alone in node-negative locally advanced cancer of the prostate. JCO. 2005;23:1192–200.